Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Alessia Pastore"'
Autor:
Luca Sala, Davide Seminati, Maddalena Mancin, Paolo Bidoli, Diego Cortinovis, Alessia Pastore, Andrea Alberti
Publikováno v:
Lung Cancer. 142:120-122
Objectives Osimertinib is a third-generation, irreversible tyrosine kinase inhibitor of the epidermal growth factor receptor (EGFR-TKI) showing longer progression free survival and overall survival than other EGFR-TKI with an improvement in tolerabil
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::713de334597ec7b91c24bbf33cda78df
https://doi.org/10.1016/j.lungcan.2020.02.019
https://doi.org/10.1016/j.lungcan.2020.02.019
Autor:
Alessia Pastore, Graziella Pinotti, Tiziana Tartaro, Olga Nigro, Alessandro Tuzi, Elena Bolzacchini
Publikováno v:
Anti-Cancer Drugs. 30:425-427
Renal cell carcinoma (RCC) is one of the most frequent malignancies of the adults. Its incidence has been increasing steadily by 2-4% each year. Up to 30% of patients present with metastases at diagnosis. It is a highly vascularized cancer because of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::566653e5298d7f9ee4a8fa23c961df7d
https://doi.org/10.1097/cad.0000000000000742
https://doi.org/10.1097/cad.0000000000000742
Autor:
Maria L. La Targia, Giulia Quaresmini, Giuliana Muti, Anna Maria Pelizzari, Maria C. Vilardo, Eraldo Lanzi, Giuseppe Danilo Vighi, Nicola Stefano Fracchiolla, Niccolò Frungillo, M.C. Pasquini, Roberta Gaiardoni, Agostino Cortelezzi, Maurizio Bonfichi, Alessandra Ragazzi, Silvia Artuso, Dario Consonni, Federica Bocchio, Lucia Prestini, Claudia Bacci, Simona Sammassimo, Giacomo Berini, Daniele Boghi, Alessia Pastore, Alma Lisa Rivolta, Giuseppe Gritti, Massimo Magagnoli, Simone Voltolini, Elisa De Rosa, Paola Tozzi, Consuelo Corti, Livio Gargantini
Publikováno v:
Hematological oncology. 36(1)
Adverse drug reactions (ADRs) reduce patients' quality of life, increase mortality and morbidity, and have a negative economic impact on healthcare systems. Nevertheless, the importance of ADR reporting is often underestimated. The project "FarmaREL"
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c692a28bd843e8629325b1e22135c95e
https://pubmed.ncbi.nlm.nih.gov/28771763
https://pubmed.ncbi.nlm.nih.gov/28771763
Publikováno v:
Journal of Clinical Oncology. 37:e17548-e17548
e17548 Background: the Neutrophil-to-Lymphocytes ratio (NLR) and the Platelet-to-Lymphocytes ratio (PLR) represent potential prognostic markers in different tumor types. The purpose of our study was to investigate the prognostic role of the pretreatm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::267a3aeb42ad5f135709eadb45718105
https://doi.org/10.1200/jco.2019.37.15_suppl.e17548
https://doi.org/10.1200/jco.2019.37.15_suppl.e17548